semaglutide bone density GLP-1 Agonists and Orthopedic Surgery: A Review of Their Impact on Metabolism, Wound Healing, and Surgical Outcomes GLP-1s and bone loss!
Description
Anderson, FASAE, CAE, IOM President & Chief Executive Officer Date: June 4, 2026 Beginning July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will launch the Medicare GLP-1 Bridge Program, a temporary demonstration designed to provide
There's a fundamental shift underway in the pharmaceutical industry
As a key regulator of glucose levels, GLP-1 helps the body release insulin in
Observational studies in autoimmune rheumatic diseases (ARDs) such as rheumatoid arthritis and systemic lupus erythematosus indicate
